E. Laurensse
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
Papers in
-
- Adenosine and Purinergic Signaling 5
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Godefridus J. PetersHerbert M. PinedoA. LeyvaC.J. van GroeningenJ. LankelmaJorge NadalH. M. PinedoGilberto Schwartsmann
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)JNCI Journal of the National Cancer Institute (2 papers)British Journal of Cancer (2 papers)Advances in experimental medicine and biology (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- NetherlandsColombia
In The Last Decade
E. Laurensse
21 papers receiving 589 citations
Peers
Comparison fields: 5 of 78
- Physiology 68
- Oncology 249
- Infectious Diseases 130
- Molecular Biology 408
- Cancer Research 75
Countries citing papers authored by E. Laurensse
This map shows the geographic impact of E. Laurensse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Laurensse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Laurensse more than expected).
Fields of papers citing papers by E. Laurensse
This network shows the impact of papers produced by E. Laurensse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Laurensse. The network helps show where E. Laurensse may publish in the future.
Co-authors
The 21 scholars most cited alongside E. Laurensse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Development, characterization and application of an antibody against 5-fluoro-2'deoxyuridine-5'monophosphate, the active metabolite of 5-fluorouracil. | 1993 | 6 |
| 2 | 1991 | 55 | |
| 3 | In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients. | 1990 | 74 |
| 4 | 1990 | 25 | |
| 5 | 1989 | 56 | |
| 6 | 1989 | 33 | |
| 7 | 1989 | 5 | |
| 8 | 1988 | 60 | |
| 9 | 1988 | 30 | |
| 10 | 1988 | 2 | |
| 11 | 1987 | 72 | |
| 12 | 1987 | 68 | |
| 13 | 1987 | 18 | |
| 14 | 1986 | 8 | |
| 15 | 1986 | 1 | |
| 16 | 1985 | 17 | |
| 17 | 1984 | 31 | |
| 18 | 1984 | 27 | |
| 19 | 1984 | 6 | |
| 20 | 1982 | 12 |
About E. Laurensse
E. Laurensse is a scholar working on Physiology, Clinical Biochemistry, Infectious Diseases, Oncology and Molecular Biology, having authored 21 papers that have together received 609 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (12 papers), HIV/AIDS drug development and treatment (7 papers), Adenosine and Purinergic Signaling (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Metabolism and Genetic Disorders (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Alcoholism and Thiamine Deficiency (2 papers). The work is most often cited by research in Physiology (68 citations), Oncology (249 citations), Infectious Diseases (130 citations), Molecular Biology (408 citations) and Cancer Research (75 citations). E. Laurensse has collaborated with scholars based in Netherlands and Colombia. Frequent co-authors include Godefridus J. Peters, Herbert M. Pinedo, A. Leyva, C.J. van Groeningen, J. Lankelma, Jorge Nadal, H. M. Pinedo, Gilberto Schwartsmann, W J van der Vijgh and Jerry van Dijk. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, JNCI Journal of the National Cancer Institute, British Journal of Cancer, Advances in experimental medicine and biology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.